Trevi Therapeutics to Report Second Quarter 2026 Financial Results and Provide a Corporate Update on August 6, 2026
Go back to Trevi Therapeutics to Report Second Quarter 2026 Financial Results and Provide a Corporate Update on August 6, 2026| (NASDAQ: TRVI) | Delayed: 14.81 -0.14 (0.94%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $14.95 | 52 Week High | $ | |||
| Open | $14.96 | 52 Week Low | $ | |||
| Day High | $15.11 | P/E | N/A | |||
| Day Low | $14.70 | EPS | $ | |||
| Volume | 233,953 | |||||

